Presentation

Medically Ill Patient Assessment of Rivaroxaban Versus Placebo IN Reducing Post-Discharge Venous Thrombo-Embolism Risk (MARINER) Trial: Primary Results

Presenter: Alex C. Spyropoulos

August 27, 2018

REGISTER for free or LOG IN to view this content

Medically Ill Pa+ent Assessment of Rivaroxaban Versus Placebo IN Reducing Post-Discharge Venous Thrombo-Embolism Risk (MARINER) Trial: Primary Results

Clinical Cardiology

Clinical Pharma

Venous

Heart Failure

Presentation

ESC 2018

Up Next

Presentation

Durability of Transcatheter Heart Valves - Worse, Similar, or Better than Surgical Valves?

Presenter: Davide Capodanno

August 27, 2018

More slides +

Presentation

ASCEND A Randomized Trial of Omega-3 Fatty Acids (fish oil) vs Placebo

Presenter: Jane Armitage

August 27, 2018

Presentation

ASCEND Randomized placebo-controlled trial of aspirin

Presenter: Jane Armitage

August 27, 2018

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.